Latest Nanosphere Inc (NSPH) Headlines
Nanosphere to Present at the 26th Annual ROTH Conference
GlobeNewswire - Fri Mar 07, 2:59AM CST
Nanosphere, Inc. (Nasdaq:NSPH), a company enhancing medicine through targeted molecular diagnostics, today announced that an overview of the company's business and commercial strategy will be given by Roger Moody, Chief Financial Officer, at the 26 Annual ROTH Conference, being held at the Ritz Carlton in Dana Point, California from March 9-12, 2014.
Nanosphere to Host Investor Day on March 20th in New York
GlobeNewswire - Mon Mar 03, 7:00AM CST
Nanosphere, Inc. (Nasdaq:NSPH), a company enhancing medicine through targeted molecular diagnostics, today announced that it will host an Investor Day on Thursday, March 20, 2014, beginning at 8:00am Eastern Time, in New York City. Nanosphere's executive management team will provide an overview of the Company's strategies to drive long-term growth and enhance shareholder value, and an industry key opinion leader will offer perspective on the value of Nanosphere's molecular diagnostic offerings.
Nanosphere to Present at the 34th Annual Cowen & Company Health Care Conference
Marketwire - Wed Feb 26, 12:51PM CST
Nanosphere, Inc. (NASDAQ: NSPH), a company enhancing medicine through targeted molecular diagnostics, today announced that that an overview of the company's business and commercial strategy will be given by Michael McGarrity, President and Chief Executive Officer, at the Cowen & Company 34th Annual Health Care Conference, being held at the Boston Marriott Copley Place in Boston, Massachusetts, March 3-5, 2014.
Worldwide Nanomedicine Market Report 2013-2019: Neurology, Cardiovascular, Anti-inflammatory, Anti-infective & Oncology Applications
M2 - Wed Feb 19, 9:05AM CST
Research and Markets (http://www.researchandmarkets.com/research/4bpxtn/nanomedicine) has announced the addition of the "Nanomedicine Market - Global Industry Analysis, Size, Share,Growth, Trends and Forecast, 2013 - 2019" report to their offering. This report includes market estimations for the nanomedicine market for the forecast period 2013 - 2019. The market size is represented in terms of USD billion and the market estimates and forecasts are calculated, considering 2012 as the base year. Moreover, market trends and recent developments have been kept into account while forecasting market growth and revenue for the period 2013 - 2019. The overall nanomedicine market is segmented on the basis of application and geography and the market estimations for each of these segments, in terms of USD billion, is provided in this report. The nanomedicine market, by applications is segmented into neurological, cardiovascular, oncology, anti-inflammatory, anti-infective and other markets. The nanomedicine market is also estimated and analyzed on the basis of geographic regions such as North America, Europe, Asia-Pacific and rest of the world. The global trends such as drivers, restraints and opportunities of the global nanomedicine market is detailed in the market overview chapter of this report., with a view on impact of these factors on market growth along the course of the forecast period. The chapter on competitive landscape consists of heat map analysis of the key players operating in the global nanomedicine market. Some of the key players of this market include GE Healthcare, Mallinckrodt plc, Nanosphere Inc., Pfizer Inc., Merck & Co Inc., Celgene Corporation, CombiMatrix Corporation, Abbott Laboratories and others. The role of these market players in the global nanomedicine market is analyzed by profiling them on the basis of attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. The global nanomedicine market is categorized into the following segments: - Neurology - Cardiovascular - Anti-Inflammatory - Anti-Infectives - Oncology - Others Key Topics Covered: Chapter 1 Preface Chapter 2 Executive Summary Chapter 3 Global Nanomedicine Market Overview Chapter 4 Global Nanomedicine Market, by Applications Chapter 5 Global Nanomedicine Market, by Geography Chapter 6 Recommendations Chapter 7 Company Profiles - Abbott Laboratories - Celgene Corporation - CombiMatrix Corporation - GE Healthcare - Johnson & Johnson - Mallinckrodt plc. - Merck & Company Inc. - Nanosphere, Inc. - Pfizer Inc. - Sigma-Tau Pharmaceuticals Inc. - Teva Pharmaceutical Industries Ltd. - UCB SA For more information visit http://www.researchandmarkets.com/research/4b...nomedicine
MarketLive Launches New Partner Program 'MarketLive Connect'
Marketwire - Thu Feb 13, 11:54AM CST
MarketLive, the leading Total Commerce platform for high-growth merchants, today announced MarketLive Connect, a partner network of technology providers who contribute a wide range of commerce solutions to extend the capabilities of MarketLive's core platform. Examples of technology extensions include retargeting to improve conversion, social commerce integrations to expand marketshare and drive customer loyalty, and payment solutions to lower barriers to closing sales online.
Upgrade Alert for Nanosphere (NSPH)
Comtex SmarTrend(R) - Thu Feb 13, 7:05AM CST
Nanosphere (NASDAQ:NSPH) was upgraded from Neutral to Buy at Roth Capital today. The stock closed yesterday at $2.37 on volume of 1.4 million shares, above average daily volume of 663,000. Nanosphere share prices have moved between a 52-week high of $4.49 and a 52-week low of $1.72 and closed yesterday at 38% above that low price at $2.37 per share. The 200-day and 50-day moving averages have moved 0.33% lower and 0.1% lower over the past week, respectively.
Hot Stock: Nanosphere, Shares Gain 7.4% (NSPH)
Comtex SmarTrend(R) - Wed Feb 12, 10:41AM CST
Nanosphere (NASDAQ:NSPH) is one of today's best performing low-priced stocks, up 7.4% to $2.31 on 1.1x average daily volume. Nanosphere has traded 752,000 shares thus far today, vs. average volume of 664,000 shares per day. The stock has outperformed the Dow (7.4% to the Dow's -0.3%) and outperformed the S&P 500 (7.4% to the S&P's -0.1%) during today's trading.
Nanosphere Announces Fourth Quarter and Full Year 2013 Results and 2014 Guidance
Marketwire - Wed Feb 12, 7:01AM CST
Nanosphere, Inc. (NASDAQ: NSPH)
March for Real Jobs - President Zuma Must Rein in His Troops [press release]
All Africa Global Media - Wed Feb 05, 2:42AM CST
We note reports of thousands of ANC members being bussed in to Central Johannesburg today to form a 'ring of steel' around Luthuli House. They obviously never got the memo that the DA's 'March for Six Million REAL Jobs was' postponed following the JMPD's initial prohibition of it.
Nanosphere to Release Fourth Quarter and Year-End 2013 Results and Hold Investor Conference Call on Wednesday, February 12, 2014
Marketwire - Wed Jan 29, 10:30AM CST
Nanosphere, Inc. (NASDAQ: NSPH), a company enhancing medicine through targeted molecular diagnostics, today announced that it will report its results for the fourth quarter and year-end 2013 on Wednesday, February 12, 2014. The company will also hold a live investor conference call and webcast at 10:00am Eastern/7:00am Pacific.
Nanosphere Announces Expansion of Test Menu, Customer Base and Revenues
Marketwire - Fri Jan 10, 7:00AM CST
Nanosphere, Inc. (NASDAQ: NSPH) --
Health Care Sector Technical Pulse:Medtronic, Align Technology, Becton, Dickinson and Co., and Nanosphere
PR Newswire - Wed Jan 08, 7:00AM CST
On Tuesday, January 07, 2014, the U.S. equity market ended on a positive note with the S&P 500 ending the day at 1,837.88, up 0.61%; the Dow Jones Industrial Average closing at 16,530.94, up 0.64%; and the NASDAQ Composite finishing at 4,153.18, up 0.96%. The S&P 500 Health Care Sector Index gained 1.01% to end the day at 644.13; and the same has advanced 0.84% in the previous three trading sessions and 9.79% in the last three months, outperforming the S&P 500, which has advanced 0.32% and 9.65% during the respective periods. The major movers in the Health Care Sector included Medtronic Inc. (NYSE: MDT), Align Technology Inc. (NASDAQ: ALGN), Becton Dickinson and Company (NYSE: BDX), and Nanosphere Inc. (NASDAQ: NSPH). All these companies are tracked by AAAResearchReports.com. Download free technical analysis and charting reports on MDT, ALGN, BDX, and NSPH now at:
Equity Technical Coverage: Align Technology, Medtronic, Nanosphere, and Becton, Dickinson and Co.
PR Newswire - Tue Dec 10, 11:24AM CST
Editor Note: For more information about this release, please scroll to bottom.
Nanosphere to Present at the 25th Annual Piper Jaffray Healthcare Conference
Marketwire - Tue Nov 26, 7:01AM CST
Nanosphere, Inc. (NASDAQ: NSPH), a company enhancing medicine through targeted molecular diagnostics, today announced that an overview of the company's business and commercial strategy will be given by Nanosphere's Chief Executive Officer Michael McGarrity at the 25th Annual Piper Jaffray Healthcare Conference, being held at The New York Palace Hotel in New York City, from December 3-4, 2013. The Nanosphere presentation is on Tuesday, December 3 at 11:30 am Eastern Time.
Stock to Watch: Nanosphere Down 8.4% (NSPH)
Comtex SmarTrend(R) - Mon Nov 18, 11:11AM CST
Nanosphere (NASDAQ:NSPH) is one of today's worst performing low-priced stocks, down 8.4% to $2.28 on 1.1x average daily volume. Nanosphere has traded 649,000 shares thus far today, vs. average volume of 605,000 shares per day. The stock has underperformed the Dow (-8.4% to the Dow's 0.3%) and underperformed the S&P 500 (-8.4% to the S&P's 0.1%) during today's trading.
Before the Bell Scans: Medtronic Inc., Align Technology Inc., Becton, Dickinson and Co., and Nanosphere Inc.
PR Newswire - Thu Nov 14, 5:25PM CST
The U.S. equity market posted gains on Wednesday, November 13, 2013. All three benchmark indexes rose, with the S&P 500, the Dow Jones Industrial Average, and the NASDAQ Composite rising 0.81%, 0.45% and 1.16%, respectively. Shares in the healthcare sector finished on a mixed note, even as the broader market advanced. The major movers in the sector included Medtronic Inc. (NYSE: MDT), Align Technology Inc. (NASDAQ: ALGN), Becton, Dickinson and Co. (NYSE: BDX), and Nanosphere Inc. (NASDAQ: NSPH). All these companies are tracked by AAAResearchReports.com. Free technical research on MDT, ALGN, BDX, and NSPH can be downloaded upon signing up at:
Nanosphere to Present at the Credit Suisse 2013 Healthcare Conference
Marketwire - Fri Nov 08, 7:01AM CST
Nanosphere, Inc. (NASDAQ: NSPH), a company enhancing medicine through targeted molecular diagnostics, today announced that an overview of the company's business and commercial strategy will be given by Nanosphere's Chief Financial Officer Roger Moody at the Credit Suisse 2013 Healthcare Conference, being held at The Phoenician, Scottsdale in Scottsdale, Arizona from November 11-14, 2013. The Nanosphere presentation is on Wednesday, November 13 at 12:30 pm Eastern Time.
Traders Get Bullish on Shares of Nanosphere, Shares Up 7.0% (NSPH)
Comtex SmarTrend(R) - Thu Nov 07, 12:48PM CST
Nanosphere (NASDAQ:NSPH) is one of today's best performing low-priced stocks, up 7.0% to $2.09 on 1.2x average daily volume. Thus far today, Nanosphere has traded 651,000 shares, vs. average volume of 553,000 shares per day. The stock has outperformed the Dow (7.0% to the Dow's -0.5%) and outperformed the S&P 500 (7.0% to the S&P's -0.7%) during today's trading.
5 Stocks Under $10 Set to Soar
at The Street - Thu Nov 07, 12:33PM CST
Nanosphere Announces Third Quarter Results
Marketwire - Wed Nov 06, 7:01AM CST
Nanosphere, Inc. (NASDAQ: NSPH)
Nanosphere to Present at the 26th Annual ROTH Conference
GlobeNewswire - Fri Mar 07, 2:59AM CST
Nanosphere, Inc. (Nasdaq:NSPH), a company enhancing medicine through targeted molecular diagnostics, today announced that an overview of the company's business and commercial strategy will be given by Roger Moody, Chief Financial Officer, at the 26 Annual ROTH Conference, being held at the Ritz Carlton in Dana Point, California from March 9-12, 2014.
Nanosphere to Host Investor Day on March 20th in New York
GlobeNewswire - Mon Mar 03, 7:00AM CST
Nanosphere, Inc. (Nasdaq:NSPH), a company enhancing medicine through targeted molecular diagnostics, today announced that it will host an Investor Day on Thursday, March 20, 2014, beginning at 8:00am Eastern Time, in New York City. Nanosphere's executive management team will provide an overview of the Company's strategies to drive long-term growth and enhance shareholder value, and an industry key opinion leader will offer perspective on the value of Nanosphere's molecular diagnostic offerings.
Nanosphere to Present at the 34th Annual Cowen & Company Health Care Conference
Marketwire - Wed Feb 26, 12:51PM CST
Nanosphere, Inc. (NASDAQ: NSPH), a company enhancing medicine through targeted molecular diagnostics, today announced that that an overview of the company's business and commercial strategy will be given by Michael McGarrity, President and Chief Executive Officer, at the Cowen & Company 34th Annual Health Care Conference, being held at the Boston Marriott Copley Place in Boston, Massachusetts, March 3-5, 2014.
Worldwide Nanomedicine Market Report 2013-2019: Neurology, Cardiovascular, Anti-inflammatory, Anti-infective & Oncology Applications
M2 - Wed Feb 19, 9:05AM CST
Research and Markets (http://www.researchandmarkets.com/research/4bpxtn/nanomedicine) has announced the addition of the "Nanomedicine Market - Global Industry Analysis, Size, Share,Growth, Trends and Forecast, 2013 - 2019" report to their offering. This report includes market estimations for the nanomedicine market for the forecast period 2013 - 2019. The market size is represented in terms of USD billion and the market estimates and forecasts are calculated, considering 2012 as the base year. Moreover, market trends and recent developments have been kept into account while forecasting market growth and revenue for the period 2013 - 2019. The overall nanomedicine market is segmented on the basis of application and geography and the market estimations for each of these segments, in terms of USD billion, is provided in this report. The nanomedicine market, by applications is segmented into neurological, cardiovascular, oncology, anti-inflammatory, anti-infective and other markets. The nanomedicine market is also estimated and analyzed on the basis of geographic regions such as North America, Europe, Asia-Pacific and rest of the world. The global trends such as drivers, restraints and opportunities of the global nanomedicine market is detailed in the market overview chapter of this report., with a view on impact of these factors on market growth along the course of the forecast period. The chapter on competitive landscape consists of heat map analysis of the key players operating in the global nanomedicine market. Some of the key players of this market include GE Healthcare, Mallinckrodt plc, Nanosphere Inc., Pfizer Inc., Merck & Co Inc., Celgene Corporation, CombiMatrix Corporation, Abbott Laboratories and others. The role of these market players in the global nanomedicine market is analyzed by profiling them on the basis of attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. The global nanomedicine market is categorized into the following segments: - Neurology - Cardiovascular - Anti-Inflammatory - Anti-Infectives - Oncology - Others Key Topics Covered: Chapter 1 Preface Chapter 2 Executive Summary Chapter 3 Global Nanomedicine Market Overview Chapter 4 Global Nanomedicine Market, by Applications Chapter 5 Global Nanomedicine Market, by Geography Chapter 6 Recommendations Chapter 7 Company Profiles - Abbott Laboratories - Celgene Corporation - CombiMatrix Corporation - GE Healthcare - Johnson & Johnson - Mallinckrodt plc. - Merck & Company Inc. - Nanosphere, Inc. - Pfizer Inc. - Sigma-Tau Pharmaceuticals Inc. - Teva Pharmaceutical Industries Ltd. - UCB SA For more information visit http://www.researchandmarkets.com/research/4b...nomedicine
MarketLive Launches New Partner Program 'MarketLive Connect'
Marketwire - Thu Feb 13, 11:54AM CST
MarketLive, the leading Total Commerce platform for high-growth merchants, today announced MarketLive Connect, a partner network of technology providers who contribute a wide range of commerce solutions to extend the capabilities of MarketLive's core platform. Examples of technology extensions include retargeting to improve conversion, social commerce integrations to expand marketshare and drive customer loyalty, and payment solutions to lower barriers to closing sales online.
Upgrade Alert for Nanosphere (NSPH)
Comtex SmarTrend(R) - Thu Feb 13, 7:05AM CST
Nanosphere (NASDAQ:NSPH) was upgraded from Neutral to Buy at Roth Capital today. The stock closed yesterday at $2.37 on volume of 1.4 million shares, above average daily volume of 663,000. Nanosphere share prices have moved between a 52-week high of $4.49 and a 52-week low of $1.72 and closed yesterday at 38% above that low price at $2.37 per share. The 200-day and 50-day moving averages have moved 0.33% lower and 0.1% lower over the past week, respectively.
Hot Stock: Nanosphere, Shares Gain 7.4% (NSPH)
Comtex SmarTrend(R) - Wed Feb 12, 10:41AM CST
Nanosphere (NASDAQ:NSPH) is one of today's best performing low-priced stocks, up 7.4% to $2.31 on 1.1x average daily volume. Nanosphere has traded 752,000 shares thus far today, vs. average volume of 664,000 shares per day. The stock has outperformed the Dow (7.4% to the Dow's -0.3%) and outperformed the S&P 500 (7.4% to the S&P's -0.1%) during today's trading.
Nanosphere Announces Fourth Quarter and Full Year 2013 Results and 2014 Guidance
Marketwire - Wed Feb 12, 7:01AM CST
Nanosphere, Inc. (NASDAQ: NSPH)
March for Real Jobs - President Zuma Must Rein in His Troops [press release]
All Africa Global Media - Wed Feb 05, 2:42AM CST
We note reports of thousands of ANC members being bussed in to Central Johannesburg today to form a 'ring of steel' around Luthuli House. They obviously never got the memo that the DA's 'March for Six Million REAL Jobs was' postponed following the JMPD's initial prohibition of it.
Nanosphere to Release Fourth Quarter and Year-End 2013 Results and Hold Investor Conference Call on Wednesday, February 12, 2014
Marketwire - Wed Jan 29, 10:30AM CST
Nanosphere, Inc. (NASDAQ: NSPH), a company enhancing medicine through targeted molecular diagnostics, today announced that it will report its results for the fourth quarter and year-end 2013 on Wednesday, February 12, 2014. The company will also hold a live investor conference call and webcast at 10:00am Eastern/7:00am Pacific.
Nanosphere Announces Expansion of Test Menu, Customer Base and Revenues
Marketwire - Fri Jan 10, 7:00AM CST
Nanosphere, Inc. (NASDAQ: NSPH) --
Health Care Sector Technical Pulse:Medtronic, Align Technology, Becton, Dickinson and Co., and Nanosphere
PR Newswire - Wed Jan 08, 7:00AM CST
On Tuesday, January 07, 2014, the U.S. equity market ended on a positive note with the S&P 500 ending the day at 1,837.88, up 0.61%; the Dow Jones Industrial Average closing at 16,530.94, up 0.64%; and the NASDAQ Composite finishing at 4,153.18, up 0.96%. The S&P 500 Health Care Sector Index gained 1.01% to end the day at 644.13; and the same has advanced 0.84% in the previous three trading sessions and 9.79% in the last three months, outperforming the S&P 500, which has advanced 0.32% and 9.65% during the respective periods. The major movers in the Health Care Sector included Medtronic Inc. (NYSE: MDT), Align Technology Inc. (NASDAQ: ALGN), Becton Dickinson and Company (NYSE: BDX), and Nanosphere Inc. (NASDAQ: NSPH). All these companies are tracked by AAAResearchReports.com. Download free technical analysis and charting reports on MDT, ALGN, BDX, and NSPH now at:
Equity Technical Coverage: Align Technology, Medtronic, Nanosphere, and Becton, Dickinson and Co.
PR Newswire - Tue Dec 10, 11:24AM CST
Editor Note: For more information about this release, please scroll to bottom.
Nanosphere to Present at the 25th Annual Piper Jaffray Healthcare Conference
Marketwire - Tue Nov 26, 7:01AM CST
Nanosphere, Inc. (NASDAQ: NSPH), a company enhancing medicine through targeted molecular diagnostics, today announced that an overview of the company's business and commercial strategy will be given by Nanosphere's Chief Executive Officer Michael McGarrity at the 25th Annual Piper Jaffray Healthcare Conference, being held at The New York Palace Hotel in New York City, from December 3-4, 2013. The Nanosphere presentation is on Tuesday, December 3 at 11:30 am Eastern Time.
Stock to Watch: Nanosphere Down 8.4% (NSPH)
Comtex SmarTrend(R) - Mon Nov 18, 11:11AM CST
Nanosphere (NASDAQ:NSPH) is one of today's worst performing low-priced stocks, down 8.4% to $2.28 on 1.1x average daily volume. Nanosphere has traded 649,000 shares thus far today, vs. average volume of 605,000 shares per day. The stock has underperformed the Dow (-8.4% to the Dow's 0.3%) and underperformed the S&P 500 (-8.4% to the S&P's 0.1%) during today's trading.
Before the Bell Scans: Medtronic Inc., Align Technology Inc., Becton, Dickinson and Co., and Nanosphere Inc.
PR Newswire - Thu Nov 14, 5:25PM CST
The U.S. equity market posted gains on Wednesday, November 13, 2013. All three benchmark indexes rose, with the S&P 500, the Dow Jones Industrial Average, and the NASDAQ Composite rising 0.81%, 0.45% and 1.16%, respectively. Shares in the healthcare sector finished on a mixed note, even as the broader market advanced. The major movers in the sector included Medtronic Inc. (NYSE: MDT), Align Technology Inc. (NASDAQ: ALGN), Becton, Dickinson and Co. (NYSE: BDX), and Nanosphere Inc. (NASDAQ: NSPH). All these companies are tracked by AAAResearchReports.com. Free technical research on MDT, ALGN, BDX, and NSPH can be downloaded upon signing up at:
Nanosphere to Present at the Credit Suisse 2013 Healthcare Conference
Marketwire - Fri Nov 08, 7:01AM CST
Nanosphere, Inc. (NASDAQ: NSPH), a company enhancing medicine through targeted molecular diagnostics, today announced that an overview of the company's business and commercial strategy will be given by Nanosphere's Chief Financial Officer Roger Moody at the Credit Suisse 2013 Healthcare Conference, being held at The Phoenician, Scottsdale in Scottsdale, Arizona from November 11-14, 2013. The Nanosphere presentation is on Wednesday, November 13 at 12:30 pm Eastern Time.
Traders Get Bullish on Shares of Nanosphere, Shares Up 7.0% (NSPH)
Comtex SmarTrend(R) - Thu Nov 07, 12:48PM CST
Nanosphere (NASDAQ:NSPH) is one of today's best performing low-priced stocks, up 7.0% to $2.09 on 1.2x average daily volume. Thus far today, Nanosphere has traded 651,000 shares, vs. average volume of 553,000 shares per day. The stock has outperformed the Dow (7.0% to the Dow's -0.5%) and outperformed the S&P 500 (7.0% to the S&P's -0.7%) during today's trading.
5 Stocks Under $10 Set to Soar
at The Street - Thu Nov 07, 12:33PM CST
Nanosphere Announces Third Quarter Results
Marketwire - Wed Nov 06, 7:01AM CST
Nanosphere, Inc. (NASDAQ: NSPH)
